Bromazolam Powder
$300.00$250.00
Bromazolam, systematically named 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine, is a synthetic triazolobenzodiazepine (TBZD) derivative first synthesized in the 1970s. With the molecular formula C₁₇H₁₃BrN₄ (molecular weight 353.22 g/mol) and CAS number 71368-80-4, bromazolam is structurally characterized by a bromine substitution at the 8-position and a triazole ring fused to the benzodiazepine core—making it the bromo analog of alprazolam (where chlorine is replaced by bromine).
Supplied as a high-purity, fine white to off-white crystalline powder, our bromazolam is strictly intended for in vitro laboratory research, analytical reference material applications, forensic toxicology studies, and pharmacological investigations into GABA_A receptor modulation, benzodiazepine structure-activity relationships, non-subtype-selective agonist binding profiles (with reported affinities such as ~2.81 nM at α₁, ~0.69 nM at α₂, and ~0.62 nM at α₅ subtypes), or comparative neurochemical profiling of triazolobenzodiazepines.
Researchers may utilize bromazolam to examine central nervous system depressant mechanisms, allosteric modulation of chloride ion channels, or metabolic pathways in controlled experimental environments aimed at advancing understanding of designer benzodiazepines and related novel psychoactive substances.